Open an Account
search icon
3
NOTIFICATIONS
Best Algo trading app in India

Back Stocks profile

Stock analysis tool for investors

Vanta Bioscience Ltd.

NSE: VANTA | BSE:540729

₹56.60 2.00 (3.66%) 1D

Diversified Consumer Services

Buy Sell

Open an Account with Bigul in 5 minutes

Performance

Today’s low

56.60

Today’s High

57.00

52W low

37.00

52W High

101.60

Open Price

57.00

Prev. Close

55.5300

Volume

1500.00

Value

84900.00

Fundamentals

Market Cap

35.70

Price to Earnings

0.00

Price to Book Value

1.90

Dividend Yield

0.00

PE to Growth

0.00

Op Revenue TTM

0.00

Net Profit TTM

0.00

Cash From Operating Activity

-0.63

Return on Equity %

-37.00

EMA & SMA

Bullish Moving Averages

7

Bearish Moving Averages

9

5Day EMA

53.7

10Day EMA

53.2

12Day EMA

53.5

20Day EMA

55.2

26Day EMA

56.6

50Day EMA

59.8

100Day EMA

61.4

200Day EMA

68.1

5Day SMA

53

10Day SMA

51.7

20Day SMA

54

30Day SMA

58.7

50Day SMA

65.7

100Day SMA

60.4

150Day SMA

58.5

200Day SMA

61

DELIVERY AND VOLUME

DAILY AVG. DELIVERY VOLUME %

05 Jul, 2024

100

Week

100

Month

99.1

LEGEND

Positive Indicator

Neutral Indicator

Negative Indicator

RESISTANCE AND SUPPORT

56.72

PIVOT

First Resistance

56.83

Second Resistance

57.07

Third Resistance

57.18

First Support

56.48

Second Support

56.37

Third Support

56.13

Relative Strength Index

49.57

Money Flow Index

66.49

MACD

-3.16

MACD Signal

-3.98

Average True Range

2.68

Average Directional Index

27.62

Rate of Change (21)

-19.14

Rate of Change (125)

6.79

Commodity Channel Index

65

Williams %R

-3.2

BETA

1 Month

-0.93

3 Month

-0.32

1 Year

-0.47

3 Year

-0.09

PRICE CHANGE ANALYSIS

↑ 8.85%

1 Week

Low

High

50

56.95

↑ 1.93%

1 Month

Low

High

46.04

58.3

↓ -11.56%

3 Months

Low

High

46.04

75.24

↓ -4.07%

6 Months

Low

High

46.04

101.64

↑ 34.76%

1 Year

Low

High

37

101.64

Indicator Graph
Total Qtr Revenue cr
Operating Expenses Qtr
Operating Profit Qtr
EBIDT Qtr Cr
Depreciation Qtr
Net Profit Qtr
Basic EPS Qtr
Indicator Mar 2023 Mar 2022 Mar 2021 Mar 2020 Mar 2019 Graph
Total Revenue Annual 5.80 9.52 10.06 14.22 12.65
Operating Expenses Annual Cr 5.65 5.95 6.14 9.80 9.16
Operating Profit Annual -0.48 3.40 3.89 4.32 3.27
Operating Profit Margin Annual % -8.20 35.74 38.70 30.35 25.83
Total Expenses Annual Cr 10.00 9.38 9.45 12.93 11.56
EBIDT Annual Cr 0.15 3.57 3.92 4.43 3.50
EBIDT Annual margin % 2.58 37.50 38.92 31.12 27.64
Depreciation 1.25 1.32 1.25 1.19 0.71
PAT Before ExtraOrdinary Items Annual Cr -4.24 0.08 0.47 0.98 0.69
Net Profit Annual -4.24 0.08 0.47 0.98 0.69
Basic EPS Annual -6.71 0.12 0.75 1.55 1.17
Indicator Mar 2023 Mar 2022 Mar 2021 Mar 2020 Mar 2019 Graph
Total ShareHolders Funds Annual 19.74 23.99 23.91 23.44 22.25
Minority Interest Liability Annual Cr - - - - -
Total Non Current Liabilities Annual Cr 21.65 16.43 11.49 11.02 12.57
Total Current Liabilities Annual Cr 10.25 9.98 10.85 7.13 3.19
Total Capital Plus Liabilities Annual Cr 51.64 50.40 46.25 41.59 38.00
Fixed Assets Annual 37.40 36.12 29.39 20.76 21.60
Total Non Current Assets Annual 40.51 39.40 32.74 24.11 23.95
Total Current Assets Annual 11.13 11.00 13.51 17.48 14.05
Total Assets Annual 51.64 50.40 46.25 41.59 38.00
Contingent Liabilities plus Commitments Annual Cr 0.00 0.00 0.00 0.00 0.00
Indicator Mar 2023 Mar 2022 Mar 2021 Mar 2020 Mar 2019 Graph
Cash from Operating Activity Annual 0.64 6.70 10.91 2.95 -0.29
Cash from Investing Activity Annual -2.53 -8.05 -9.86 -1.35 -4.48
Cash from Financing Annual Activity 1.88 1.38 -1.07 -1.80 4.96
Net Cash Flow Annual -0.00 0.03 -0.02 -0.20 0.20
Indicator Mar 2023 Mar 2022 Mar 2021 Mar 2020 Mar 2019 Graph
Book Value Per Share Annual 31.28 38.01 37.88 37.13 35.24
ROE Annual % -21.45 0.32 1.96 4.17 3.11
ROCE Annual % -2.65 5.57 7.52 9.39 8.00
Total Debt to Total Equity Annual 1.30 0.87 0.56 0.53 0.55
EBDIT Annual Margin % 2.89 38.17 39.00 31.35 28.14
Indicator Graph
Total Qtr Revenue cr
Operating Expenses Qtr
Operating Profit Qtr
EBIDT Qtr Cr
Depreciation Qtr
Net Profit Qtr
Basic EPS Qtr
Indicator Mar 2023 Mar 2022 Mar 2021 Mar 2020 Mar 2019 Graph
Total Revenue Annual 6.96 10.11 10.07 14.25 12.65
Operating Expenses Annual Cr 8.67 6.22 6.09 9.77 9.15
Operating Profit Annual -2.39 3.47 3.95 4.37 3.27
Operating Profit Margin Annual % -34.38 34.30 39.17 30.65 25.87
Total Expenses Annual Cr 17.23 9.88 9.48 12.91 11.55
EBIDT Annual Cr -1.71 3.89 3.98 4.48 3.50
EBIDT Annual margin % -24.51 38.49 39.52 31.43 27.68
Depreciation 2.67 1.32 1.25 1.19 0.71
PAT Before ExtraOrdinary Items Annual Cr -10.44 0.13 0.45 1.01 0.70
Net Profit Annual -6.48 0.09 0.45 1.00 0.70
Basic EPS Annual -10.27 0.14 0.07 1.56 1.10
Indicator Mar 2023 Mar 2022 Mar 2021 Mar 2020 Mar 2019 Graph
Total ShareHolders Funds Annual 17.51 24.01 23.92 23.47 22.25
Minority Interest Liability Annual Cr 1.41 5.34 2.31 0.99 0.98
Total Non Current Liabilities Annual Cr 48.03 37.78 28.56 14.24 12.57
Total Current Liabilities Annual Cr 17.75 14.28 14.84 9.87 3.20
Total Capital Plus Liabilities Annual Cr 84.71 81.40 69.63 48.57 39.00
Fixed Assets Annual 67.83 64.59 48.73 27.76 21.60
Total Non Current Assets Annual 69.47 66.91 49.69 28.73 21.95
Total Current Assets Annual 15.24 14.50 19.94 19.85 17.05
Total Assets Annual 84.71 81.40 69.63 48.57 39.00
Contingent Liabilities plus Commitments Annual Cr 0.00 0.00 0.00 0.00 0.00
Indicator Mar 2023 Mar 2022 Mar 2021 Mar 2020 Mar 2019 Graph
Cash from Operating Activity Annual -0.63 5.28 -37.52 2.11 -1.27
Cash from Investing Activity Annual -5.91 -17.18 22.19 -7.35 -5.50
Cash from Financing Annual Activity 6.41 9.53 17.78 2.17 9.94
Net Cash Flow Annual -0.13 -2.37 2.46 -3.07 3.18
Indicator Mar 2023 Mar 2022 Mar 2021 Mar 2020 Mar 2019 Graph
Book Value Per Share Annual 29.99 46.49 41.55 38.75 36.80
ROE Annual % -37.00 0.36 1.87 4.28 3.13
ROCE Annual % -6.53 3.83 4.98 8.50 7.79
Total Debt to Total Equity Annual 3.26 1.87 1.34 0.66 0.55
EBDIT Annual Margin % -27.19 40.16 39.65 31.66 28.19
Name Holding Percent Holding Id Pledged % Locked %
Name Holding Percent Holding Id Pledged % Locked %
MOHAN KRISHNA MULAKALA 55.22 75290049 0 0
DOPESH RAJA MULAKALA 7.26 75290050 0 0
S CHANDRA SEKHAR RAO 1.94 75290051 0 0
SOUMYA SIMHADRI 1.43 75290052 0 0
SHRAVAN CHINTAPATLA 1.27 75290053 0 0
MULAKALA KARISHMA 0.79 75290054 0 0
VYASMURTI MADHAVRAO SHINGATGERI 0.79 75290055 0 0
Name Holding Percent Holding Id
Name Holding Percent Holding Id
M SHIKAR 1.28 75290064
VIMALCHAND A . 1.09 75290065
EMILY BOSCO MENEZES 1.02 75290066
BOSCO ARMANDO MENEZES 1.01 75290067
Ex-Date Dividend Amount Dividend Type Record Date Instrument Type
Ex-Date Split Ratio Record Date
Ex-Date Purpose Notes
Nov 14, 2023 Half Yearly Results -
Aug 10, 2023 Audited Results -
May 30, 2023 Audited Results & Half Yearly Results -
Nov 14, 2022 Half Yearly Results -
May 30, 2022 Audited Results -
Nov 11, 2021 Half Yearly Results -
Jun 28, 2021 Audited Results & Preferential Issue (Revised)
Jun 23, 2021 Audited Results & Preferential Issue -
Nov 13, 2020 Half Yearly Results -
Jun 30, 2020 Audited Results -
Nov 13, 2019 Half Yearly Results -
May 22, 2019 Audited Results -
Nov 09, 2018 Quarterly Results -
May 21, 2018 Audited Results -
Nov 10, 2017 Quarterly Results -
Ex-Date Bonus Ratio Record Date
Bigul
21 Apr 2024

Vanta Bioscience Ltd - 540729 - Compliance Certificate Under Regulation 40(9)

 Compliance Certificate under Regulation 40(9)
Bigul
21 Apr 2024

Vanta Bioscience Ltd - 540729 - Reg. 34 (1) Annual Report.

 Annual Report for FY 2021-22
Bigul
21 Apr 2024

Vanta Bioscience Ltd - 540729 - Compliance Certificate Under Regulation 7(3)

 Compliance Certificate under Regulation 7(3)
Bigul
02 Apr 2024

Vanta Bioscience Ltd - 540729 - Announcement under Regulation 30 (LODR)-Award of Order Receipt of Order

 Receipt of order worth Rs. 1.2 Cr for technical studies
Bigul
01 Apr 2024

Vanta Bioscience Ltd - 540729 - Appointment of Company Secretary and Compliance Officer

 Appointment of CS and Compliance Officer w.e.f 01.04.2024
Bigul
30 Mar 2024

Vanta Bioscience Ltd - 540729 - Closure of Trading Window

 Closure of Trading Window
Bigul
01 Dec 2023

Vanta Bioscience Ltd - 540729 - Announcement under Regulation 30 (LODR)-Award of Order Receipt of Order

 Receipt of order worth Rs. 57 Lakh for GLP Studies
Bigul
14 Nov 2023

Vanta Bioscience Ltd - 540729 - Change In Designation Of Dr. Vyasmurti Madhavrao Shingatgeri (DIN 07728757) From Whole Time Director To Non-Executive Director W.E.F 14.11.2023.

 Change in Designation of Dr. Vyasmurti Madhavrao Shingatgeri from WTD to Non Executive Director w.e.f 14.11.2023
Bigul
14 Nov 2023

Vanta Bioscience Ltd - 540729 - Board Meeting Outcome for Outcome Of Board Meeting Held On 14.11.2023

 Outcome of Board Meeting held on 14.11.2023
Bigul
08 Nov 2023

Vanta Bioscience Ltd - 540729 - Board Meeting Intimation for Approval Of Unaudited Financial Statements For The Period Ended 30.09.2023

 Vanta Bioscience Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 14/11/2023 ,inter alia, to consider and approve the un-audited financial results of the Company for the half year ended 30.09.2023 and to take note of the Statutory Auditors' limited review reports thereon.
See all News

FAQs

The latest market price of Vanta Bioscience Ltd. on NSE was Rs. 56.60 as of today.

The opening share price of Vanta Bioscience Ltd. was Rs. 57.00 as of today.

The 52-week high share price of Vanta Bioscience Ltd. was Rs. 101.60.

The 52 week low share price of Vanta Bioscience Ltd. was Rs. 37.00.

Please find Corporate actions section for more details.

The PE ratio of Vanta Bioscience Ltd. is 0.00. Please refer to the Fundamentals section for further details.

Please find Corporate actions section for more details.

Please find Corporate actions section for more details.

Please refer to Stock Ants, Bigul’s Community Access platform that aggregates tips and research from experts and provides real-time tracking to help investors validate, discover new investment ideas, and make informed decisions. Click here to learn more.

Please refer to Stock Ants, Bigul’s Community Access platform that aggregates tips and research from experts and provides real-time tracking to help investors validate, discover new investment ideas, and make informed decisions. Click here to learn more.

Please find Corporate actions section for more details.

Please find Corporate actions section for more details.

Please find Corporate actions section for more details.

Please refer to Bigul Traders Corner, One Stop destination for different algo and non-algo trading strategies and tools meant for investors, traders, and strategists. Our qualified experts with rich experience in broking, financial analysis, and software development designed it in-house. Click here to learn more.

Please refer to JARVIS, which is Bigul’s AI Portfolio Manager Tool that uses artificial intelligence algorithms to make investment decisions in a portfolio. Click here to learn more.

Please refer to the News section for the latest news about Vanta Bioscience Ltd..

Close

Let's Open Free Demat Account